Demant stock

DEMANT · Nasdaq Copenhagen · DKK

Compare Demant
kr 349.00Change from previous close: −0.34%Absolute change: −kr 1.20

Close · November 16, 2026

Price history

+63.08% over the period

1 year: from kr 214.00 (November 17, 2025) to kr 349.00 (November 16, 2026), +63.08%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 16, 2026kr 349.00
October 30, 2026kr 365.40
September 30, 2026kr 310.00
August 31, 2026kr 288.60
July 31, 2026kr 281.00
June 30, 2026kr 268.20
May 29, 2026kr 250.20
April 30, 2026kr 202.00
March 31, 2026kr 193.90
February 27, 2026kr 196.80
January 30, 2026kr 220.40
December 30, 2025kr 215.20
November 28, 2025kr 219.20
November 17, 2025kr 214.00

At a glance

  • The company

    Develops, manufactures and distributes hearing aids, operates hearing care clinics, and provides hearing and balance assessment solutions

  • Latest results

    Quarter to September 30, 2026 · EPS kr 0.00 (estimate kr 0.00)

TickerLandia's take on Demant

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk lowkr 175.00
52-wk highkr 386.00

−9.59% from the 52-week high

Analysts · 20 analysts

Average targetkr 359.85+3.11% vs. price

Buy 9 · Hold 10 · Sell 1 · Buy

TickerLandia Fingerprint: Demant

Compared with similar companies: very strong momentum and very low financial strength.

Financials and price compared with 31 companies in the medical devices industry, worldwide. Momentum and risk compared with 1,160 European stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Demant is pricier than in the past and in line with similar companies

On the latest fiscal year's earnings (2025), Demant's P/E today is 31.2, above the median of its last 10 fiscal years (24.3; between 19.1 and 51.5 from 2016 to 2025). Demant's P/E (trailing 12 months): 30.5, in line with the median of a group of 10 similar companies (31.1).

P/E compared with its history

Compared with 10 similar companies

Demant's metrics compared with similar companies
MetricDemantPosition in the groupBand
P/E (trailing 12 months)30.5Middle
Forward P/E20.1Middle
Operating margin17.2%High
ROE23.3%High
Debt/equity1.79High

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Demant. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

kr 12.91B

Latest quarter · Q2 2026

Net income

kr 1.19B

Latest quarter · Q2 2026

Quarterly net margin

9.2%

Latest quarter · Q2 2026

Numbers and valuation

Full valuation
Market cap
kr 73.86B
P/E
30.5
EPS
kr 11.48
Volume
684.7K
Daily trading
€20.89M

How Demant is changing

All results
  • Revenue grew 9.7% a year on average over the last 5 years

  • Operating margin rose from 15.8% to 17.3%

  • Profits turn into cash: free cash flow equal to 181% of net income

Returns

Demant returns with dividends

kr 1,000 invested in Demant 5 years ago, on November 16, 2021, would be worth kr 1,045 today with dividends reinvested: +4.49% in total, +0.88% per year. On price alone it would be kr 1,045 (+4.49%).

PeriodDemantkr 1,000 becomes
1 month−2.73%kr 973
6 months+48.01%kr 1,480
Year to date+62.17%kr 1,622
1 year+63.08%kr 1,631
3 years+27.00%kr 1,270
5 years+4.49%kr 1,045
10 years+205.07%kr 3,051

From 1 year up with dividends reinvested, before taxes; under a year price only. Calculate your investment

The chart in detail

Demant: technical analysis

Demant is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 10.5% below its all-time closing high (kr 389.80, August 4, 2021).

Trend
Upward
RSI (14 sessions)
46
Between 30 and 70
vs 200-session average
+33.57%

Support and resistance

Price areas where Demant has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. No resistance above: the price is near the highs of the year
  2. Last pricekr 349.00
  3. Supportkr 298.80−14.38%2 touches, last on September 3, 2026
  4. Supportkr 285.60−18.17%4 touches, last on August 21, 2026
  5. Supportkr 266.13−23.74%3 touches, last on July 22, 2026

Volatility and risk

Volatility (60 sessions, annualised)
30.0%
Largest fall in the last year
−24.77%

Close of November 16, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Demant: seasonality

Average monthly price change over 32 years

+2.0%Jan+1.3%Feb+2.7%Mar+3.9%Apr+3.3%May−0.7%Jun+1.2%Jul−1.4%Aug+0.9%Sep+1.7%Oct+2.0%Nov+2.3%Dec

Over the last 32 years, the strongest month for Demant has been April: +3.93% on average, positive in 23 years out of 31. The weakest has been August: −1.45% on average, positive in 12 years out of 32. November, the current month, has been positive in 16 years out of 31 (+1.98% on average).

Show chart data
MonthAverageMedianPositive years
January+1.98%+4.39%21 of 31
February+1.29%−1.32%13 of 31
March+2.69%+2.28%19 of 31
April+3.93%+3.03%23 of 31
May+3.33%+2.29%22 of 31
June−0.68%−0.43%14 of 32
July+1.23%+0.80%17 of 32
August−1.45%−1.98%12 of 32
September+0.91%+1.48%19 of 32
October+1.69%+0.38%16 of 32
November+1.98%+0.64%16 of 31
December+2.27%+2.38%22 of 31

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Demant and its competitors

Hearing aids are the core of the business of this Danish group, which develops and manufactures them and sells them at wholesale level. Alongside these devices it owns and operates hearing care clinics, where patients are tested and fitted. It also supplies diagnostic tools for testing hearing and balance to professionals such as audiologists, ENT specialists and balance clinics. Its activities reach customers across Europe, North America, Asia, the Pacific region and other markets abroad.

Headquarters
Smørum, Denmark
Employees
26,616
Founded
1904
Chief executive
Søren Nielsen
Demant and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
DemantDEMANT$10.92B17.2%30.5+48.01%
Smith & NephewSN.$13.03B14.2%21.4+5.76%
GetingeGETI.B$7.63B14.3%27.1+49.29%
SectraSECT.B$6.17B20.6%99.9+27.79%
Sonova HoldingSOON$20.24B19.5%31.7+61.25%
Koninklijke PhilipsPHIA$29.64B8.8%66.9+26.10%

Same industry or related industries, similar size. Compare Demant with its competitors · Full profile